Market Cap 8.22B
Revenue (ttm) 675.04M
Net Income (ttm) 141.21M
EPS (ttm) N/A
PE Ratio 61.79
Forward PE 51.48
Profit Margin 20.92%
Debt to Equity Ratio 0.00
Volume 1,141,900
Avg Vol 1,832,718
Day's Range N/A - N/A
Shares Out 106.05M
Stochastic %K 10%
Beta 0.22
Analysts Strong Sell
Price Target $138.25

Latest News on CORT

Big Money Keeps Buying Corcept

Jan 29, 2025, 7:37 AM EST - 4 months ago

Big Money Keeps Buying Corcept


Corcept Therapeutics Generating Strong Revenue And Profit Growth

Jan 22, 2025, 2:03 PM EST - 4 months ago

Corcept Therapeutics Generating Strong Revenue And Profit Growth